IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Similar documents
IVC-MEITAR HIGH-TECH EXITS 2015 REPORT 2015 exits peak at $9.02B 3 rd strongest year in 10 years

Israel Venture Capital Investments Report Q3 2017

FUNDS DATABASE SCOPE INCLUSION CRITERIA DATA HIGHLIGHTS

Silicon Valley Venture Capital Survey Second Quarter 2018

VENTURE CAPITAL INVESTING REACHES HIGHEST LEVEL SINCE Q WITH $13.0 BILLION INVESTED DURING Q2 2014, ACCORDING TO THE MONEYTREE REPORT

MoneyTreeTM. Report. Some $171 million VC financing invested in hi-tech companies in Q compared with $255 million in the second quarter 2012

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

VENTURE-BACKED IPO EXIT ACTIVITY MORE THAN DOUBLES IN Q WITH STRONGEST QUARTER FOR BIOTECH OFFERINGS SINCE 2000

Silicon Valley Venture Capital Survey Third Quarter 2017

Venture Capital Report

Overview of Venture Equity

VENTURE-BACKED IPO EXIT ACTIVITY KEEPS MOMENTUM WITH BEST FULL YEAR FOR NEW LISTINGS SINCE 2007; THIRD CONSECUTIVE QUARTER FOR 20+ OFFERINGS SINCE

Venture-Backed Exit Activity Shows Improved Signs of Life in Q1 2010

Venture Capital Industry Overview. Powered By:

Average M&A Deal Size at Highest Level Since 2004

2013 venture capital trends summary

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2011)

Moving Ahead. Third-quarter Technology venture capital investment increased 33 percent yearover-year. percent quarter-over-quarter.

Florida Venture Factbook

The percentage of Series A rounds declined significantly, to 12% of all deals.

M&A Update 1H Proven. Focused. Trusted. Accounts Receivable Management Healthcare IT Revenue Cycle Management

2013 Global venture capital confidence survey results. How confident are investors?

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

1h Fenwick. Trends in Terms of U.S. Life Science Venture Financings. First Half fenwick & west llp

Venture Capital Search Highlights

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

COLUMBUS 2020 A REGIONAL GROWTH STRATEGY FOR CENTRAL OHIO

Venture Capital Report

Digital Health Funding and M&A

International Presence, Local Expertise. Introductory Presentation

NEW GENERATION OF VCs LEADS STARTUP CEOs BACK TO THE FOLD

T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T T AND PRIVATE EQUITY ENERGIZE GROWTH

Venture Capital Report

Trends in Terms of Venture Financings In Silicon Valley (Second Quarter 2010)

Mara H. Rogers, Partner Norton Rose Fulbright

Silicon Valley Venture Capital Survey Fourth Quarter 2018

Co C m o pa p n a y n Pr P o r f o il i e l Nove v mb m e b r r

Media & Entertainment Venture Capital In The US - Industry Market Research Report [Download: PDF] [Digital] By IBISWorld READ ONLINE

2014 Global venture capital confidence survey results

Venture Capital Report

Forum Science & Business FCRi - EY Foundation

Small Business, Entrepreneurship, and Economic Recovery

VENTURE CAPITAL. Financing startup and emerging growth companies Long term/patient capital Equity financing High Risk/High Return Exits: M &A or IPO

Master Class : Excellence in Private Equity & Deal Structuring

GLOBAL RISK AND INVESTIGATIONS JAPAN CAPABILITY STATEMENT

Raising capital Healthy fundraising tension shows the market s underlying strength

SEMICONDUCTOR INDUSTRY ASSOCIATION FACTBOOK

OECD/ADBI 7th Round Table on Capital Market Reform in Asia October 2005 ADB Institute, Tokyo, Japan

ITRE Committee European Parliament Hearing on Horizon Chiara de Caro, EBAN General Manager March 20 th 2012

Venture financings in 3Q12 continued to show solid price increases from their prior round, but 3Q12 was not as strong as 2Q12.

Silicon Valley Venture Capital Survey Third Quarter 2017

Creating a University Angel Group

PANEL DISCUSSION & ROUNDTABLES

3Q13. Trends in Terms of Venture Financings in Silicon Valley. Third Quarter Fenwick. fenwick & west llp

Venture Capital Report

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

2013 Report on Angel Investing Activity in Canada

KTO co-operation with venture capitalists how to design effectively?

Inbound Flip Transactions

Financing Baltimore s Growth: Venture Capital Support for Small Companies

Accenture Technology Vision 2015 Delivering Public Service for the Future Five digital trends: A public service outlook

University of Oxford Executive Finance Programmes

Technologies Worth Watching. Case Study: Investigating Innovation Leader s

VentureSource China -- 3Q 2014

Venture Capital Report

CANADIAN PRIVATE EQUITY BUYOUT REVIEW

The Case for Scaling Corporate Venture Investment. in Tech in Europe. Findings & Insights by. 26 April 2017

Asia Pacific UK Cross border transactions. Corporate Finance PRECISE. PROVEN. PERFORMANCE.

Venture capital - An introduction into the nature of venture capital

A report on investment gender diversity in the Nordics

New York Bar admission (or eligibility to obtain admission promptly) is required.

GLOBAL PRIVATE EQUITY Report Charts

Life Sciences Outlook. New York City 2016

Angel Group Update: Q2 2013

2011 Angel Group Year in Review

Q Introduction. Investment and fundraising

Year In Review: 2017 Edition

executives are often viewed to better understand the merits of scientific over commercial solutions.

Financing Sources, Sales Pitch to Investors BARCELONA Aitana Peire Venture Valuation

ESban Financing Innovation in SMEs: the role of Business Angels 11 th December 2009, Madrid

The history and achievements of the Israeli VC industry

Business angels Published on Innovation Policy Platform (

ECSEL JU Symposium 2018 Electronics: a vision and how to get there Lessons learned from study on access-to-finance conditions. Brussels, June

Venture Capital Research Report Q4 2017

VentureSource China -- 1Q 2014

Software was the Most Active and Highest Value Segment in 3Q17 with 606 Transactions Totaling $29.4 Billion in Reported Deal Value

EVCA Strategic Priorities

State of Venture Capital in the Southeast Q Executive Summary Pacing vs. 2016*

2Q13. Trends in Terms of Venture Financings in Silicon Valley. Second Quarter fenwick & west llp

VentureSource Europe -- 3Q 2014

Trends in Healthcare Investments and Exits 2018

François G. Laugier's Representative Experience

Private Equity Market Update. February 2013

AFTER NEARLY 3 YEARS OF STEADY GROWTH, U.S. VENTURE INVESTMENT PULLS BACK 7% IN 1 ST QUARTER TO $6.84 BILLION

Angel Investor Networks The Power of Groups

Trends in Terms of U.S. Life Science Venture Financings. Full Year Fenwick. fenwick & west llp

Innovation, Creativity, and Intellectual Property Rights

Helping Businesses & Investors. Succeed Across Saudi Arabia

VENTURE IMPACT ILLINOIS THE ECONOMIC IMPACT OF VENTURE CAPITAL ON ILLINOIS

Ying Li. Proskauer.com. Partner. Hong Kong Beijing New York

Transcription:

IVC-MEITAR HIGH-TECH EXITS H1/ 215 REPORT IVC-Meitar 214 Exits Report Prepared by IVC Research Center Ltd.

Israeli High-Tech Exit Highlights Exit proceeds in H1/215 reached ¾ of total exits for 214 Average exit grew 51% compared with last year H1/215 was the 2-nd strongest half-year for M&A activity Acquisitions by Israeli companies continue their pace, reaching almost 5% of 214 which was the strongest in the past 6 years

Israeli High-Tech Exits 21 - H1/215 Israeli high-tech exits activity has accelerated to total $5.29 billion in H1/215-76% of the total exit proceeds in 214 and 8% of the total proceeds in 213. $b # 12 17 17 1. 1 91 88 8. 84 8 The average exit deal hit $98 million in H1/215, compared with the $65 million annual average in 214. 6. 4. 9.74 6.62 6.98 54 6 4 Number of exits in H1/215 reached 5% of the 214 figure and 6% of the 213 deals. 2. 2.53 5.34 5.29 2. 21 211 212 213 214 H1/215 Exit Amount $b # of Exits Source: IVC Research Center

High-Tech Exits H1/21 - H1/215 Throughout H1/215, 54 Israeli high-tech companies performed exits with a total deal value of $5.29 billion the highest half-year in a decade, second only to the exceptional H1/212 total of $8.33 billion. Average deal size in H1/215 reached $98 million, compared with $54 million and $83 million in H1/214 and H1/213, respectively. $b # 1. 58 54 52 8. 45 45 4 6. 4. 8.33 5.29 7 6 5 4 3 2 2. The $1.25 billion acquisition of Fundtech, an enterprise applications company, by D+H, an international fintech company, accounted for almost 24% of the total exit proceeds.. 2.66 3.33 3.14.89 H1/21 H1/211 H1/212 H1/213 H1/214 H1/215 Exit Amount $b # of Exits Source: IVC Research Center 1

Average Exit 21-H1/215 Average VC-backed exit in H1/215 totaled $84 million, a 15% increase from the 214 average, while non VC-backed exit average jumped 8% from $6 million last year to $18 million in H1/215 $m 16. 14. 12. 1. 14.4 115.3 18.3 VC-backed exits averaged 23% less than non VCbacked exits 8. 6. 42.5 62.4 73.3 73.1 6.1 83.8 4. 41.9 46.1 2. 22.5. 21 211 212 213 214 H1/215 Avg. non-vc Backed Exit $m Avg. VC-backed Exit $m Source: IVC Research Center

Israeli High-Tech Exits by Sector 21 - H1/215 (%) Software was a leading sector for exits in H1/215, with 15 deals totaling $2.6B the highest figure for the sector in past 6 years 55% of the total sector amount, mostly because of Fundtech s acquisition. Internet exits have grown in the last four years, reaching 17% of total exits in H1/215. The value of communications exits shrunk from 62% of the total capital proceeds in 212 to 17% in H1/215. Almost no life sciences exits were recorded in H1/215. Software, Internet, and communications led exit dealmaking in H1/215, capturing 74% of the total number of deals. H1/215 3% 214 6% 213 1% 212 % 211 1% 11% 21 % 17% 21% 32% 26% 17% 48% 1% 7% 7% 12% 28% 11% 2% 2% 5% 2% 34% 2% 6% 62% 2% 16% 9% 7% 5% 34% 13% 11% 7% 23% 11% 23% 21% 1% 18% % 1% 2% 3% 4% 5% 6% 7% 8% 9% 1% Cleantech Communications Internet IT & Enterprise Software Life Sciences Miscellaneous Technologies Semiconductors Source: IVC Research Center

VC-backed Exits Non VC-backed Exits Top Ten Exits in H1/215 $1.2b The top five non-vc-backed exits contributed 44% of total Israeli capital proceeds, while the 5 largest VC-backed exits accounted for 22% of the total. Five of the ten largest acquisitions were performed in the software industry. Borderfree acquisition captured 5% of total Internet intakes, while Annapurna deal accounted for the bulk of semiconductor exits, at 95%. Two acquisitions of subdivisions of Comverse accounted for 38% of communications exit proceeds s in this period. $45m *$272m *$175m $16m $36m $23m $2m $2m $15m Semiconductors Communications Software Internet

IPO HIGHLIGHTS IPO transactions continued in H1/215 with $38M

Israeli High-Tech IPOs 21 - H1/215 Israeli high-tech IPO activity has continued with 6 companies going public, although the deal volume is somewhat modest $38 million or just 6% of total proceeds in H1/215. Only 2 of the 6 companies that went public were venture-backed, compared with more than half of IPOs by VC-backed companies in 214. While IPO activity to date peaked in 214, more than 2 Israeli companies are currently planning to go public in 215-216, and at least 3-4 deals are scheduled to close by yearend, for a total of up to $5 million. $M # 22 18 2 16 16 18 14 16 12 14 12 9 1 1 8 25 8 8 6 5 6 6 4 4 2 2 361 38 127 126 21 211 212 213 214 H1/215 IPO Total $M # of IPOs Source: IVC Research Center

Israeli High-Tech IPOs by Stock Exchange ($m) H1/215 NASDAQ continued as the preferred stock market for Israeli high-tech companies in H1/215, with 4 IPOs accounting for 84% of IPO proceeds. The largest IPO of H1/215 was SolarEdge, which raised $126 million on NASDAQ. The remaining 5 IPOs were all under $1 million each. 48 When taking into account the actual amount raised in IPOs, companies' valuations at the time of the IPO totaled $1.3 billion in H1/215 (subsequently changing when a company has been listed). AIM NASDAQ 26 Source: IVC Research Center

HIGH-TECH MERGERS & ACQUISITIONS H1/215 M&A performance of $4.98B exceeded 214

Israeli High-Tech M&As 21 - H1/215 M&A performance in H1/215 has accelerated, with $4.98 billion in 48 deals exceeding the total 214 M&A dollar volume of $4.93 billion, partially due to Fundtech acquisition (25% of total M&A proceeds). However in terms of number of deals, H1/215 reached half of the annual M&A activity in the past 6 years. $b # 12. 12 12 1. 1 88 91 83 8. 75 8 6. 6 48 4. 4 2. 2 The average M&A deal was the second highest in the past 6 years, at $14 million.. 2.4 5.22 9.74 6.26 4.93 4.98 21 211 212 213 214 H1/215 M&A Total $B # of M&A Deals Source: IVC Research Center

Israeli High-Tech M&As H1/21 - H1/215* Israeli high-tech M&A activity shows increased total dollar proceeds in H1/215, at $3.73 billion in deals below $1B. The amount was 42% higher than the $2.62 billion in H1/214 and 77% higher than the $2.1 billion in H1/213. The average high-tech M&A deal totaled $79 million the highest in 6 years, compared with $5 million and $58 million average M&A in H1/214 and H1/213, respectively. $B # 4. 3.5 51 52 47 3. 4 41 2.5 36 2. 1.5 1..5..84 2.63 3.33 2.1 2.62 3.73 H1/21 H1/211 H1/212 H1/213 H1/214 H1/215 M&A Total $B # of M&A Deals Source: IVC Research Center *Excluding deals above $1B 6 5 4 3 2 1

M&A Deals: Deal Size Mix (# of deals vs. $m) In H1/215, M&A deal size patterns were similar to the 6-year M&A patterns. Deals in the $1-5 million range accounted for 54% of M&A proceeds in H1/215. H1/215 saw a slight increase in the $5-1 million range 13% of the total M&A proceeds, compared with the average share of 6% of the total for these deals in the past four years. There were no M&A deals in the $5-1, million range in H1/215. The number of deals under $5 million declined to 18% of the total, compared with 42% of total M&As in the past 6 years. 12 1 8 6 4 2 1 9 8 7 6 5 4 3 2 1 # $m 7 9 21 38 1254 1 16 5 51 51 517 354 6434 2475 2571 4 41 292 2689 69 387 454 711 342 246 425 672 84 99 44 82 56 59 63 91 3482 21 211 212 213 214 H1/215 2816 9 125 <$1m $1m-$5m $5m-$1m $1m-$5m >=$5m Source: IVC Research Center 29 3 1 5 19 3 11 4 1 16 5 25 28 21 211 212 213 214 H1/215 Source: IVC Research Center 1 13 9 14 11

M&As THE ACQUIRER SIDE Israeli high-tech acquirer activity accounted for 23% of total number of M&As in H1/215

H1/215 High-Tech M&As: Deals by Country of Acquirer 11 of the 48 Israeli hightech M&As in H1/215 were acquired by other Israeli companies (23% of the total), compared with 29 deals (32%) in 214. 1 9 8 4 5 9 1 India Australia East Asia United Kingdom Partial Comverse and Nice Systems sale deals accounted for 63% of total Israeli acquisitions, while Check Point acquired two Israeli companies in the first half of 215. 7 6 5 4 29 1 3 3 2 2 Mainland Europe & Russia Israel United States & Canada As in previous years, the US continued to be the main target market for Israeli exits, with 54% of total Israeli M&A deal-making in this period. 3 2 1 11 43 26 214 H1/215 Source: IVC Research Center

Acquisitions Made by Israeli High-Tech Companies 21 H1/215 We examined all M&As in which an Israeli high-tech company was the buyer, regardless of the identity of the acquired company. H1/215 saw continued activity in Israeli high-tech acquisitions performance, at 51% of 214 levels, with 24 high-tech companies making at least one acquisition for a total 32 acquisitions. The year s largest deal by an Israeli buyer was the $3.2B acquisition of Auspex Pharmaceuticals by Teva. Playtech, Comverse and Check Point each made acquisitions exceeding $1 million. Frutarom was the most active buyer in H1/215, with 5 acquisitions. It is still premature to say whether, in terms of M&A activity, 215 will match 214, which was the strongest in the past 6 years for the Israeli high-tech sector. However, as M&As prove to be a valid and effective means of company growth, 215 should be prolific, in light of the general trend in the Israeli market, as more and more growth-stage companies seek expansion. 7 6 5 4 3 2 1 63 59 5 44 47 41 35 37 32 34 28 24 21 211 212 213 214 H1/215 # of Israeli High-Tech Acquirers # of acquisitions Source: IVC Research Center

About this report: This report contains information derived from the IVC-Online Database The report summarizes exits of Israeli high-tech companies in merger & acquisition deals and initial public offerings in 21-H1/215 VC-Backed Deals referred to in this report, represent exit deals where at least one venture capital fund was involved as a pre-exit investor. The last section of the report also references M&A deals where Israeli high-tech companies acted as the acquiring party. All Rights Reserved. Copyright of IVC Research Center Ltd. 215

About Meitar Liquornik Geva Leshem Tal: Meitar Liquornik Geva Leshem Tal is Israel s largest law firm and an undisputed leader in the technology sector. The firm's Technology Group numbers over 9 seasoned professionals who specialize in representing technology companies, cooperating with attorneys from complementary practice areas, such as taxation, intellectual property and labor law, and dozens of attorneys from other practice areas. Meitar has played a significant role in the majority of the largest and most prominent transactions recorded in the Israeli technology sector, including mergers and acquisitions and public offerings on foreign stock exchanges. Meitar is uniquely qualified in the entire corporate life cycle. Meitar advises clients from their initial establishment through raising seed capital to successful exit. Alongside emerging companies, Meitar represents high growth companies, and has represented the majority of the Israeli technology companies that have carried out initial public offerings in the US, as well as a diverse range of multinational companies from the US, China and Europe. The firm represents most of the major venture capital funds active in the Israeli technology sector, and played an active role in formation of some of the most successful and well-known funds in the industry. Meitar is unique among Israel s largest law firms in the number of partners who have worked for major international law firms in the US and elsewhere. The firm maintains close working relationships with leading firms from around the world to provide our international and Israeli clients with the highest level of service and quality in line with the finest law firms from across the globe.

About IVC Research Center IVC Research Center is the leading online provider of data and analyses on Israel s high-tech, venture capital and private equity industries. IVC owns and operates the IVC-Online Database which showcases over 12, Israeli technology startups, and includes information on private companies, investors, venture capital and private equity funds, angel groups, incubators, accelerators, investment firms, professional service providers, investments, financings, exits, acquisitions, founders, key executives and R&D centers. Among IVC products and publications are: IVC-KPMG Quarterly Survey, which for over 15 years has been analyzing capital raising trends by Israeli high-tech companies, and the most comprehensive guide to Israeli high technology and venture capital The IVC High-Tech Yearbook the Israel High-Tech, Venture Capital, Startup and Private Equity Directory; surveys; research papers and reports; and interactive dashboards. IVC Industry Analytics analysis, research and insights into the status, main trends and opportunities related to exits, investments, investors, sectors and stages IVC products and services are used regularly by high-tech companies, venture capital funds, private investors, financial investors and institutions, as well as public entities such as the Central Bureau of Statistics, the Bank of Israel and the Office of the Chief Scientist at the Economy Ministry. IVC s information is used by key decision-makers, strategic and financial investors, government agencies and academic and research institutions in and outside of Israel.

CONTACT US Marianna Shapira, Research Manager, IVC Research Center +972-()73-212-2339 www.ivc-online.com